Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Candin Market Value Growth And Long-Term Outlook
The historical period experienced growth due to the imperative for immune competency assessment, the widespread adoption of DTH testing methods, the expansion of hospital diagnostic services, a surge in immunosuppressive therapies, and the overall progression of clinical immunology.
The projected growth during the forecast period can be attributed to an increasing prevalence of immunodeficiency, the broader implementation of immune monitoring protocols, a surge in diagnostic testing volumes, enhanced clinical understanding, and advancements in healthcare infrastructure. Key trends anticipated within this period include the wider application of immune function diagnostic tests, an expanded scope for assessing cell-mediated immunity, a heightened demand for diagnostic skin testing, a greater emphasis on detecting immunosuppressive disorders, and the reinforcement of hospital-based diagnostic services.
Get A Free Sample Report With In-Depth Market Insights:
Candin Market Growth Backed By Core Demand Fundamentals
The rising occurrence of tuberculosis is projected to drive the expansion of the candin market in the foreseeable future. Tuberculosis (TB) is an infectious, transmissible illness caused by the bacterium Mycobacterium tuberculosis, mainly impacting the lungs yet able to disseminate throughout the body, spread via airborne droplets from an infected individual. An uptick in tuberculosis cases stems from factors including heightened transmission from unaddressed or unidentified infections, the emergence of drug-resistant TB variants, deficiencies in healthcare availability, shifts in population, and the influence of concurrent infections such as HIV, which compromise immune function. Candin aids in managing tuberculosis by functioning as a control in dermal tests to assess cell-mediated immunity, differentiating between immune reactions resulting from Mycobacterium tuberculosis and generalized anergic responses in individuals suspected of having tuberculosis or those with impaired immune systems. For example, in November 2024, the Centers for Disease Control and Prevention, a national public health body in the US, reported that the United States saw 9,633 tuberculosis cases in 2023, indicating a 15.6% increase from the 8,332 cases registered in 2022. Consequently, the growing incidence of tuberculosis is fueling the expansion of the candin market.
Candin Market Segment Outlook: Which Categories Are Growing Fastest?
The candin market covered in this report is segmented –
1) By Indication: Candidiasis, Thrush
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
Candin Market Growth Trends Reshaping The Competitive Landscape
The key development in the candin market centers on establishing strategic partnerships aimed at providing non-invasive, cost-effective, and efficient treatment solutions. Strategic partnerships are defined as collaborative agreements between two or more organizations designed to harness each other’s strengths, resources, or specialized knowledge to achieve common goals, frequently involving shared risks, rewards, and responsibilities in areas such as product innovation, market expansion, or new developments. For example, in May 2023, Nielsen BioSciences Inc., a US-based pharmaceutical company, revealed it had entered into a licensing agreement with Maruho Co. Ltd., a Japan-based pharmaceutical company, to commercialize candin in Japan as a treatment for verruca vulgaris. As a consequence of this alliance, Maruho will make a considerable upfront payment to Nielsen and assume all costs related to the ongoing development and regulatory procedures for Candin, which is a diagnostic skin test intended for treating verruca vulgaris (common warts).
Candin Market Leading Companies And Competitive Benchmarking
Major companies operating in the candin market are Nielsen BioSciences Inc.
View The Full Candin Market Report:
Candin Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the candin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
